Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Medulloblastoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Juvenile 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Tumor Virus Infections 1Sezary Syndrome 1Rhabdoid Tumor 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Oligodendroglioma 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1HIV Infections 1

Interventions

Vincristine 2Topotecan 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Doxorubicin 2Cyclophosphamide 2Congresses as Topic 2Cisplatin 2Busulfan 21,2-diaminocyclohexaneplatinum II citrate 2etoposide phosphate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Isotretinoin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Ganglioneuroblastoma × Isotretinoin × Clear all
NCT01175356 2026-01-23

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Children's Oncology Group

Phase 1 Completed
99 enrolled 11 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡